Magnetic resonance diffusion-weighted imaging in the diagnosis of diffuse liver diseases in rats

( views:92, downloads:0 )
Author:
GUAN Sheng()
ZHOU Kang-rong()
ZHAO Wei-dong()
Peng Wei-jun()
TANG Feng()
Mao Jian()
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
Volume 118, Issue 08, 2005
DOI:
Key Word:
liver;diffusion weighted magnetic resonance imaging;rat

Abstract: Background The diagnosis of diffuse hepatic lesions in early stage is a tough task at any time for clinical conventional imaging Magnetic resonance diffusion-weighted imaging (MR DWI) can detect the changes of tissue structure at molecular level This study was designed to determine the value of DWI in the diagnosis of diffuse liver lesions in early stage.Methods Diffuse liver lesions were induced by diethylnitrosamine in 42 rats of test group. Fourteen rats in control group were fed with pure water. Dynamic changes of MR DWI were observed every week in both groups during the early stage of diffuse liver lesions (1 to 12 weeks after drug administration in the test group). Apparent diffusion coefficient (ADC) values of liver parenchyma in different stages and pathologic changes were analyzed.Results The process of diffuse hepatic lesions in the test group was classified into three stages according to pathological changes, namely hepatitis, hepatic fibrosis and cirrhosis. No obvious morphological changes were shown by conventional imaging in both groups during this stage. But MR DWI demonstrated heterogeneous signal changes in early stage of hepatic cirrhosis in the test group. No significant change of ADC values was found in the control group between different weeks (P>0.05). The ADC values of the test group declined from the fifth week, and after the tenth week the ADC values were significantly different between the test and control groups at gradient factor (b) value 300 sec/mm2 (P<0.05). At b value 600 and 1000 sec/mm2, significant difference was seen between the two groups from the sixth week onward. The range of ADC value of the groups was (1.7-0.9)±(0.40-0.04) mm2/sec (b=600) and (1.38-0.75)±(0.07-0.35) mm2/sec (b=1000), respectively. Dominant pathological changes included swelled hepatocytes within 1 to 4 weeks after the administration of diethylnitrosamine in the test group, hyperplasia of fibrous tissues in 5-8 weeks and formation of cirrhotic nodules in 9-12 weeks.Conclusions MR functional DWI could detect diffuse liver lesions earlier than conventional morphological imaging. ADC value as a marker for early diagnosis of diffuse liver lesions could also be used to inspect changes of the lesions.

  • [1]Sundgren PC, Dong Q, Gomez-Hassan D, et al. Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology 2004,46:339-350.
  • [2]Murtz P, Flacke S, Traber F, et al. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology 2002,224:258-264.
  • [3]Moteki T, Horikoshi H, Oya N, et al. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images. J Magn Reson Imaging 2002,15:564-572.
  • [4]Tomczak R, Kramer S, Fleiter T, et al. Diffusion and perfusion: principles and clinical use. Rontgenpraxis 2000,52:361-370.
  • [5]Grenier N. Diffusion-weighted MR imaging of the abdomen: a new clinical tool? J Radiol 2004,85:717-719.
  • [6]Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003,226:71-78.
  • [7]Laghi A, Catalano C, Assael FG, et al. Diffusion-weighted echo-planar sequences for the evaluation of the upper abdomen: technique optimization. Radiol Med 2001,101:213-218.
  • [8]Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003,16:132-136.
  • [9]Khvorostinka VM, Il'chenko IA, Bobronnikova LR. Variations of treatment of chronic alcohol diffusion liver disease. Lik Sprava 2001:154-155.
  • [10]Ichikawa T, Haradome H, Hachiya J, et al. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 1999,24:456-461.
  • [11]Kim T, Murakami T, Takahashi S, et al. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999,173:393-398.
  • [12]Amano Y, Kumazaki T, Ishihara M. Single-shot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phased-array multicoil. Acta Radiol 1998,39:440-442.
  • [13]Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004,232:685-692.
  • [14]Aube C, Racineux PX, Lebigot J, et al. Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results. J Radiol 2004,85:301-306.
  • [15]Chow LC, Bammer R, Moseley ME, et al. Single breath-hold diffusion-weighted imaging of the abdomen. J Magn Reson Imaging 2003,18:377-382.
  • [16]Yamada I, Aung W, Himeno Y, et al. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999,210:617-623.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn